Dashboard
Manage Tickers

ERNA Eterna Therapeutics Inc.

Nasdaq brooklynitx.com


$ 1.32 $ 0.03 (2.33 %)    

Wednesday, 15-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 602.46 $ 4.22 (0.71 %)
DIA $ 462.89 $ 0.00 (0 %)
SPY $ 665.00 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.35 $ 6.60 (1.73 %)
$ 1.32
$ 1.29
$ 1.30 x 1,030
$ 1.37 x 1,000
$ 1.26 - $ 1.32
$ 1.09 - $ 18.75
20,183
na
10.13M
$ 7.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-12-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-20-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 07-01-2022 03-31-2022 10-Q
15 04-15-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-20-2020 03-31-2020 10-Q
23 03-19-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-22-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-09-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ernexa-therapeutics-to-present-preclinical-data-on-gene-modified-ips-derived-mscs-reprogramming-immune-microenvironment-in-high-grade-serous-ovarian-cancer-at-aacr-conference-on-september-20
Ernexa Therapeutics To Present Preclinical...
09/17/2025 12:36:50

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/15/2025 21:06:07

correction-ernexa-therapeutics-cuts-operating-loss-decreased-by-55m-or-51-from-107m-during-the-6-months-ending-on-june-30-2024-to-52m-during-the-6-months-ending-on-june-30-2025
CORRECTION: Ernexa Therapeutics Cuts Opera...
09/10/2025 12:49:30

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/09/2025 21:06:08

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/29/2025 21:06:12

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
07/25/2025 21:06:49

ernexa-therapeutics-regains-nasdaq-compliance
Ernexa Therapeutics Regains Nasdaq Compliance
07/09/2025 12:35:19

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 17:06:36

ernexa-therapeutics-receives-6m-in-second-closing-under-securities-purchase-agreement-with-certain-accredited-investors
Ernexa Therapeutics Receives ~$6M In Secon...
06/24/2025 12:31:56

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
06/12/2025 12:55:07

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/11/2025 23:50:05

ernexa-therapeutics-announces-1-for-15-reverse-stock-split-effective-june-12-2025
Ernexa Therapeutics Announces 1-For-15 Rev...
06/10/2025 13:31:21

Ernexa Therapeutics (NASDAQ:ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune dis...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

reported-june-2-2025-ernexa-therapeutics-amends-certificate-of-incorporation-to-increase-authorized-common-stock-from-100m-to-150m-shares
Reported June 2, 2025: Ernexa Therapeutics...
06/03/2025 14:50:51

Effective June 2, 2025, Ernexa Therapeutics Inc. (the "Company"), filed a certificate of amendment to the Company's...

ernexa-therapeutics-establishes-texas-subsidiary-to-support-ongoing-development-of-erna-101-and-future-clinical-operations
Ernexa Therapeutics Establishes Texas Subs...
05/14/2025 12:35:15

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/17/2025 21:05:38

rnexa-therapeutics-files-prospectus-for-resale-of-104m-shares-of-common-stock
Rnexa Therapeutics Files Prospectus For Re...
04/16/2025 20:34:57

-SEC Filing

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/03/2025 21:05:48

eterna-therapeutics-changes-name-to-ernexa-therapeutics
Eterna Therapeutics Changes Name to Ernexa...
03/25/2025 12:31:20

Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced th...

eterna-therapeutics-announces-inaugural-scientific-advisory-board-meeting-discussed-erna-101-preclinical-advances-in-ovarian-cancer-focused-on-immune-activation-tumor-microenvironment-combination-therapies-and-erna-102-for-autoimmune-diseases
Eterna Therapeutics Announces Inaugural Sc...
02/26/2025 13:45:40

Some highlights from the meeting include:The board discussed the positive preclinical data for ERNA-101 in ovarian cancer, incl...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION